Suppression of intestinal microbiota-dependent production of pro-atherogenic trimethylamine N-oxide by shifting L-carnitine microbial degradation

J Kuka, E Liepinsh, M Makrecka-Kuka, J Liepins… - Life sciences, 2014 - Elsevier
Abstract Aims Trimethylamine-N-oxide (TMAO) is produced in host liver from trimethylamine
(TMA). TMAO and TMA share common dietary quaternary amine precursors, carnitine and …
被引用次数：118 相关文章

[引用][C] Suppression of intestinal microbiota-dependent production of pro-atherogenic trimethylamine N-oxide by shifting L-carnitine microbial degradation

J Kuka, E Liepinsh, M Makrecka-Kuka, H Cirule… - Life Sciences, 2014 - elibrary.ru
[PDF] academia.edu

[PDF][PDF] Suppression of intestinal microbiota-dependent production of pro-atherogenic trimethylamine N-oxide by shifting L-carnitine microbial degradation

J Kuka, E Liepinsh, M Makrecka-Kuka, J Liepins… - 2014 - academia.edu
Aims: Trimethylamine-N-oxide (TMAO) is produced in host liver from trimethylamine (TMA).
TMAO and TMA share common dietary quaternary amine precursors, carnitine and choline …

Suppression of intestinal microbiota-dependent production of pro-atherogenic trimethylamine N-oxide by shifting L-carnitine microbial degradation.

J Kuka, E Liepinsh, M Makrecka-Kuka, J Liepins… - Life …, 2014 - europepmc.org
Aims Trimethylamine-N-oxide (TMAO) is produced in host liver from trimethylamine (TMA).
TMAO and TMA share common dietary quaternary amine precursors, carnitine and choline …

Suppression of intestinal microbiota-dependent production of pro-atherogenic trimethylamine N-oxide by shifting L-carnitine microbial degradation

J Kuka, E Liepinsh, M Makrecka-Kuka… - Life …, 2014 - pubmed.ncbi.nlm.nih.gov
Aims Trimethylamine-N-oxide (TMAO) is produced in host liver from trimethylamine (TMA).
TMAO and TMA share common dietary quaternary amine precursors, carnitine and choline …

Suppression of intestinal microbiota-dependent production of pro-atherogenic trimethylamine n-oxide by shifting l-carnitine microbial degradation.

J Kuka, E Liepinsh, M Makrecka-Kuka, J Liepins… - 2014 - cabidigitallibrary.org
Abstract Aims: Trimethylamine-N-oxide (TMAO) is produced in host liver from trimethylamine
(TMA). TMAO and TMA share common dietary quaternary amine precursors, carnitine and …

Suppression of intestinal microbiota-dependent production of pro-atherogenic trimethylamine N-oxide by shifting L-carnitine microbial degradation

J Kuka, E Liepinsh, M Makrecka-Kuka, J Liepins… - Life Sciences, 2014 - infona.pl
Trimethylamine-N-oxide (TMAO) is produced in host liver from trimethylamine (TMA). TMAO
and TMA share common dietary quaternary amine precursors, carnitine and choline, which …

Suppression of intestinal microbiota-dependent production of pro-atherogenic trimethylamine N-oxide by shifting L-carnitine microbial degradation

J Kuka, E Liepinsh, M Makrecka-Kuka, J Liepins… - Life Sciences, 2014 - infona.pl
Trimethylamine-N-oxide (TMAO) is produced in host liver from trimethylamine (TMA). TMAO
and TMA share common dietary quaternary amine precursors, carnitine and choline, which …

[引用][C] Suppression of intestinal microbiota-dependent production of pro-atherogenic trimethylamine N-oxide by shifting L-carnitine microbial degradation

J Kuka, E Liepinsh, M Makrecka-Kuka, J Liepins… - 2014